Mark S. Smyth
Impact in
- Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 6
- Chemical Synthesis and Analysis 5
- Protein Tyrosine Phosphatases 4
- PI3K/AKT/mTOR signaling in cancer 4
-
- Organophosphorus compounds synthesis 4
- Carbohydrate Chemistry and Synthesis 4
- Co-authors
- Terrence R. Burke (14 shared papers)Peter P. Roller (6 shared papers)Motoyoshi Nomizu (5 shared papers)Akira Otaka (4 shared papers)Arthur G. Schultz (3 shared papers)Harry Ford (1 shared paper)Akihisa Otaka (2 shared papers)Congcong Sun (3 shared papers)
- Journals
- Tetrahedron Letters (7 papers)Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Blood (2 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Mark S. Smyth
32 papers receiving 1.5k citations
Mark S. Smyth's Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 209
- Hematology 292
- Organic Chemistry 686
- Molecular Biology 1.1k
- Oncology 332
Countries citing papers authored by Mark S. Smyth
This map shows the geographic impact of Mark S. Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Smyth more than expected).
Fields of papers citing papers by Mark S. Smyth
This network shows the impact of papers produced by Mark S. Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Smyth. The network helps show where Mark S. Smyth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Smyth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome Hit paper breakdown → | 2007 | 542 |
| 2 | 1994 | 171 | |
| 3 | 1993 | 136 | |
| 4 | 1992 | 106 | |
| 5 | 1995 | 99 | |
| 6 | 1994 | 76 | |
| 7 | 1993 | 70 | |
| 8 | 1996 | 56 | |
| 9 | 1995 | 56 | |
| 10 | 1993 | 42 | |
| 11 | 1997 | 35 | |
| 12 | 1993 | 32 | |
| 13 | 1993 | 28 | |
| 14 | 1993 | 24 | |
| 15 | 1994 | 16 | |
| 16 | 1997 | 15 | |
| 17 | 2002 | 14 | |
| 18 | 2004 | 14 | |
| 19 | 2001 | 13 | |
| 20 | 2005 | 13 |
About Mark S. Smyth
Mark S. Smyth is a scholar working on Molecular Biology, Organic Chemistry, Hematology, Oncology and Pharmaceutical Science, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Chemical Synthesis and Analysis (5 papers), Protein Tyrosine Phosphatases (4 papers), Organophosphorus compounds synthesis (4 papers), Carbohydrate Chemistry and Synthesis (4 papers), Fluorine in Organic Chemistry (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Pharmaceutical Science (209 citations), Hematology (292 citations), Organic Chemistry (686 citations), Molecular Biology (1.1k citations) and Oncology (332 citations). Mark S. Smyth has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Terrence R. Burke, Peter P. Roller, Motoyoshi Nomizu, Akira Otaka, Arthur G. Schultz, Harry Ford, Akihisa Otaka, Congcong Sun, Tina M. Woo and Tonia J. Buchholz. Their work appears in journals such as Tetrahedron Letters, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Blood and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.